[ADRO] Aduro Biotech, Inc.


Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 11 Change: 0.95 (9.45%)
Ext. hours: Change: 0 (0%)

chart ADRO

Refresh chart

Strongest Trends Summary For ADRO

ADRO is in the medium-term down -29% in 4 months and down -67% below S&P in 6 months. In the long-term down -98% below S&P in 6 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities22.31 M Cash From Investing Activities-310 K Cash From Operating Activities-8.47 M Gross Profit
Net Profit-16.62 M Operating Profit-7.28 M Total Assets138.76 M Total Current Assets136.96 M
Total Current Liabilities40.72 M Total Debt1.1 M Total Liabilities51.05 M Total Revenue9.57 M
Technical Data
High 52 week7.85 Low 52 week1.26 Last close1.32 Last change-4.35%
RSI49.33 Average true range0.1 Beta1.32 Volume206.2 K
Simple moving average 20 days-3.47% Simple moving average 50 days-18.34% Simple moving average 200 days-55.85%
Performance Data
Performance Week-2.22% Performance Month-12.58% Performance Quart-58.75% Performance Half-60.6%
Performance Year-74.62% Performance Year-to-date-50% Volatility daily3.88% Volatility weekly8.68%
Volatility monthly17.8% Volatility yearly61.65% Relative Volume205.44% Average Volume452.81 K
New High New Low


2019-10-02 16:05:00 | Aduro Biotech Announces Two Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 34th Annual Meeting SITC 2019

2019-09-30 16:05:00 | Aduro Biotech to Present at the 2019 Cantor Global Healthcare Conference

2019-09-19 09:49:55 | Do Insiders Own Lots Of Shares In Aduro BioTech, Inc. NASDAQ:ADRO?

2019-09-04 08:30:00 | Aduro Biotech Announces First Patient Dosed in Phase 2 Study of ADU-S100 MIW815 in Combination with KEYTRUDA® pembrolizumab for First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma HNSCC

2019-09-03 16:05:00 | Aduro Biotech to Present at the H.C. Wainwright 21st Annual Global Investment Conference

2019-08-31 09:31:01 | Why Is Aduro Biotech ADRO Down 12.1% Since Last Earnings Report?

2019-08-14 14:32:40 | Who Has Been Selling Aduro BioTech, Inc. NASDAQ:ADRO Shares?

2019-08-05 10:46:02 | Aduro ADRO Earnings Miss in Q2, Revenues Meet Estimates

2019-08-01 16:05:00 | Aduro Biotech Provides Business Update and Reports Second Quarter 2019 Financial Results

2019-07-31 10:36:02 | Aduro Biotech ADRO May Report Negative Earnings: Know the Trend Ahead of Q2 Release

2019-07-16 11:04:03 | AbbVie ABBV Acquires Mavupharma to Boost Cancer Portfolio

2019-06-04 10:32:02 | Aduro Stock Crashes After ASCO Updates on Cancer Candidate

2019-06-02 11:45:00 | Aduro Biotech and Novartis Present Results from Ongoing Phase 1b Study of STING Agonist ADU-S100 MIW815 in Combination with Anti-PD-1 Monoclonal Antibody Spartalizumab PDR001 in Patients with Advanced Solid Tumors or Lymphomas

2019-05-20 16:53:09 | Health Care Digest: Cancer's show-and-tell meeting, a new biotech building rises and lupus patients' plea

2019-05-15 17:06:00 | Aduro Biotech to Host Investor Event Featuring ADU-S100 MIW815 Clinical Data Presented at the 2019 American Society of Clinical Oncology Annual Meeting

2019-05-15 17:05:00 | Aduro Biotech Announces Clinical Program Update for Anti-APRIL Antibody BION-1301

2019-05-08 12:06:04 | Aduro ADRO Q1 Earnings and Revenues Fall Shy of Estimates

2019-05-07 18:45:10 | Aduro Biotech ADRO Reports Q1 Loss, Misses Revenue Estimates

2019-05-07 16:54:08 | What's in Store for Axsome AXSM This Earnings Season?

2019-05-07 16:05:00 | Aduro Biotech Reports First Quarter 2019 Financial Results

2019-05-07 10:53:02 | Guardant Health GH to Report Q1 Earnings: What's in Store?

2019-05-07 10:47:02 | Proteostasis PTI to Post Q1 Earnings: What's in Store?

2019-05-06 16:13:08 | Soleno Therapeutics SLNO to Post Q1 Earnings: What's Up?

2019-05-06 15:06:07 | What's in the Cards for Perrigo PRGO This Earnings Season?

2019-05-06 11:54:03 | Assertio Therapeutics ASRT to Post Q1 Earnings: What's Up?

2019-05-03 17:22:09 | Mylan MYL to Report Q1 Earnings: What's in the Offing?

2019-05-03 10:32:02 | What's in Store for Sorrento SRNE This Earnings Season?

2019-05-02 10:58:02 | PDL BioPharma PDLI to Post Q1 Earnings: What's in Store?

2019-05-01 18:07:10 | Is a Beat in the Cards for Mallinckrodt MNK Q1 Earnings?

2019-04-30 11:39:03 | AVEO Pharmaceuticals AVEO to Post Q1 Earnings: What's Up?

2019-04-30 09:15:01 | Small Gains Still Bring New Highs

2019-04-30 08:16:12 | What's in the Cards for Bausch Health BHC Q1 Earnings?

2019-04-29 18:14:10 | Is a Beat in the Cards for Incyte INCY in Q1 Earnings?

2019-04-28 23:52:03 | Sangamo SGMO Q1 Earnings: What's in Store for the Stock?

2019-04-26 11:48:03 | Universal Health UHS Q1 Earnings, Revenues Miss Estimates

2019-04-26 11:42:03 | What's in Store for HCA Healthcare's HCA Q1 Earnings?

2019-04-26 11:38:03 | Is a Beat in Store for WellCare Health's WCG Q1 Earnings?

2019-04-25 11:55:03 | Tenet Healthcare THC to Post Q1 Earnings: What's in Store?

2019-04-25 11:15:03 | Is a Beat in Store for Editas EDIT This Earnings Season?

2019-04-25 09:27:01 | The Zacks Analyst Blog Highlights: Incyte, Aduro Biotech, MeiraGTx and Coherus BioSciences

2019-04-24 16:32:08 | What's in Store for Vertex VRTX This Earnings Season?

2019-04-24 12:06:04 | What's in the Cards for Amarin AMRN This Earnings Season?

2019-04-24 11:43:03 | Trevena TRVN to Post Q1 Earnings: What Awaits the Stock?

2019-04-24 11:25:03 | Anthem's ANTM Q1 Earnings Beat Estimates, Improve Y/Y

2019-04-24 10:33:02 | Aduro Biotech ADRO Expected to Beat Earnings Estimates: Can the Stock Move Higher?

2019-04-24 09:11:01 | 5 Biotech Stocks Defying the Medicare-for-All Scare

2019-04-22 11:08:03 | Exact Sciences EXAS to Post Q1 Earnings: What's in Store?

2019-04-22 10:33:02 | Is a Beat in Store for AbbVie ABBV This Earnings Season?

2019-04-22 08:15:00 | Aduro Biotech Appoints Dimitry S.A. Nuyten, M.D., Ph.D. as Chief Medical Officer

2019-04-18 16:05:00 | Aduro Biotech Appoints Experienced Financial Executive, Frank Karbe, to its Board of Directors